FabiFlu replaced multivitamin drug Zincovit as the top selling drug as India witnessed the highest number of Covid infections, hospitalisations and deaths in April.
Indian social media has been inundated with posts about Covid — from availability or lack of oxygen and hospital beds to treatment options. What an analysis of Google Trends found.
Indian pharma industry launched 44 new antiviral brands in 2020, against just 10 such launches in 2019. However, total number of new brands saw 40% decline.
Modi govt's subject expert committee rejects Glenmark's proposal by highlighting that its justifications to conduct trials of favipiravir with dexamethasone were 'not adequate'.
Study will note clinical improvement of Covid patients & assess safety of favipiravir. It will also see ‘mortality, disease progression & viral clearance’ at given stages.
Glenmark conducted phase 3 clinical trials of favipiravir on 150 mild to moderate Covid patients. Adverse events, or side effects, reported in 32 patients.
The conglomerate will likely face stiff competition in the sector from existing global giants such as Unilever, as well as Indian tycoon Mukesh Ambani’s Reliance Industries.
China's People's Liberation Army aims for multiple routes to counter any possible operations by the Indian forces on the southern banks of the Pangong Tso in the future.
Like the car, nothing the party has done to reinvent itself has worked. Only way forward is to offer something looking towards the future, not in image of glorious past.